KENNESAW, Ga. and NEW HOPE, Pa., Nov. 12, 2014 /PRNewswire/ -- Clinical Trial Marketing Communications, a firm specializing in patient recruitment and retention for clinical trials announces that it has recently celebrated its tenth anniversary.
Founded in the fall of 2004 by Ken Wallace and Matthew Hayden, CTMC has become a premier provider of innovative integrated marketing solutions to help pharmaceutical sponsors, and other companies involved in drug and medical device development complete their clinical trials faster and less expensively.
"Our plan from the beginning was to keep CTMC a small business focused on high-quality work and hands-on customer service," said Ken Wallace, President of CTMC. "In this day and age it is more challenging than ever to run a small business over the long term. Our commitment to innovation and creativity and to our clients has allowed CTMC to thrive for the past decade and positions us to succeed well into the foreseeable future."
CTMC is an integrated marketing agency focused exclusively on influencing patient behavior, specifically in the clinical trial environment. CTMC's marketing communications programs are innovative solutions based on a thorough understanding of each clinical trial's therapeutic category, patient population and patient motivators. By combining its in-house expertise and capabilities with the specialized services of strategic partners, CTMC provides clients with the best of both worlds: experience, flexibility and dedication coupled with extensive healthcare marketing resources. CTMC is headquartered just outside of Atlanta in Kennesaw, Georgia. The Company also has an office in New Hope, Pennsylvania.
About Ken Wallace, MBA
Ken Wallace has spent the past 20 years planning, developing and executing marketing programs to support patient recruitment and retention for clinical trials. Prior to founding Clinical Trial Marketing Communications (CTMC), he served in many capacities at a patient recruitment company, Clinical Solutions, most recently President and Chief Operating Officer. He earned his Bachelor's Degree from Glassboro State College (now Rowan University) and his Master's in Business Administration from Kennesaw State University.
SOURCE Clinical Trial Marketing Communications